Literature DB >> 33504803

Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis.

Avia Watson1, Hao Li2,3, Bingting Ma4, Ronen Weiss1, Daniele Bendayan5, Lilach Abramovitz1, Noam Ben-Shalom1, Michael Mor1, Erica Pinko5, Michal Bar Oz6, Zhenqi Wang2, Fengjiao Du7, Yu Lu7, Jan Rybniker8,9, Rony Dahan10, Hairong Huang11, Daniel Barkan6, Ye Xiang12, Babak Javid13,14, Natalia T Freund15.   

Abstract

Mycobacterium tuberculosis (Mtb) exposure drives antibody responses, but whether patients with active tuberculosis elicit protective antibodies, and against which antigens, is still unclear. Here we generate monoclonal antibodies from memory B cells of one patient to investigate the B cell responses during active infection. The antibodies, members of four distinct B cell clones, are directed against the Mtb phosphate transporter subunit PstS1. Antibodies p4-36 and p4-163 reduce Mycobacterium bovis-BCG and Mtb levels in an ex vivo human whole blood growth inhibition assay in an FcR-dependent manner; meanwhile, germline versions of p4-36 and p4-163 do not bind Mtb. Crystal structures of p4-36 and p4-170, complexed to PstS1, are determined at 2.1 Å and 2.4 Å resolution, respectively, to reveal two distinctive PstS1 epitopes. Lastly, a prophylactic p4-36 and p4-163 treatment in Mtb-infected Balb/c mice reduces bacterial lung burden by 50%. Our study shows that inhibitory anti-PstS1 B cell responses arise during active tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33504803     DOI: 10.1038/s41467-021-20930-0

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  43 in total

1.  Antibodies to Mycobacterium tuberculosis.

Authors:  Arturo Casadevall
Journal:  N Engl J Med       Date:  2017-01-19       Impact factor: 91.245

Review 2.  Tuberculosis.

Authors:  Madhukar Pai; Marcel A Behr; David Dowdy; Keertan Dheda; Maziar Divangahi; Catharina C Boehme; Ann Ginsberg; Soumya Swaminathan; Melvin Spigelman; Haileyesus Getahun; Dick Menzies; Mario Raviglione
Journal:  Nat Rev Dis Primers       Date:  2016-10-27       Impact factor: 52.329

3.  Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2.

Authors:  C A Scanga; V P Mohan; K Yu; H Joseph; K Tanaka; J Chan; J L Flynn
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

4.  Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Franca Del Nonno; Andrea Baiocchini; Linda Petrone; Valentina Vanini; Hermelijn H Smits; Fabrizio Palmieri; Delia Goletti; Tom H M Ottenhoff
Journal:  PLoS Pathog       Date:  2016-06-15       Impact factor: 6.823

5.  Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.

Authors:  Tingting Chen; Caroline Blanc; Anke Z Eder; Rafael Prados-Rosales; Ana Camila Oliveira Souza; Ryung S Kim; Aharona Glatman-Freedman; Maju Joe; Yu Bai; Todd L Lowary; Rachel Tanner; Michael J Brennan; Helen A Fletcher; Helen McShane; Arturo Casadevall; Jacqueline M Achkar
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

6.  Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis.

Authors:  Natalie Zimmermann; Verena Thormann; Bo Hu; Anne-Britta Köhler; Aki Imai-Matsushima; Camille Locht; Eusondia Arnett; Larry S Schlesinger; Thomas Zoller; Mariana Schürmann; Stefan He Kaufmann; Hedda Wardemann
Journal:  EMBO Mol Med       Date:  2016-11-02       Impact factor: 12.137

Review 7.  Lipoarabinomannan in Active and Passive Protection Against Tuberculosis.

Authors:  Margarida Correia-Neves; Christopher Sundling; Andrea Cooper; Gunilla Källenius
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

8.  Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.

Authors:  Amanda Ardain; Racquel Domingo-Gonzalez; Shibali Das; Samuel W Kazer; Nicole C Howard; Alveera Singh; Mushtaq Ahmed; Shepherd Nhamoyebonde; Javier Rangel-Moreno; Paul Ogongo; Lan Lu; Duran Ramsuran; Maria de la Luz Garcia-Hernandez; Tyler K Ulland; Matthew Darby; Eugene Park; Farina Karim; Laura Melocchi; Rajhmun Madansein; Kaylesh Jay Dullabh; Micah Dunlap; Nancy Marin-Agudelo; Takashi Ebihara; Thumbi Ndung'u; Deepak Kaushal; Alexander S Pym; Jay K Kolls; Adrie Steyn; Joaquín Zúñiga; William Horsnell; Wayne M Yokoyama; Alex K Shalek; Henrik N Kløverpris; Marco Colonna; Alasdair Leslie; Shabaana A Khader
Journal:  Nature       Date:  2019-06-05       Impact factor: 49.962

9.  T-cell activation is an immune correlate of risk in BCG vaccinated infants.

Authors:  Helen A Fletcher; Margaret A Snowden; Bernard Landry; Wasima Rida; Iman Satti; Stephanie A Harris; Magali Matsumiya; Rachel Tanner; Matthew K O'Shea; Veerabadran Dheenadhayalan; Leah Bogardus; Lisa Stockdale; Leanne Marsay; Agnieszka Chomka; Rachel Harrington-Kandt; Zita-Rose Manjaly-Thomas; Vivek Naranbhai; Elena Stylianou; Fatoumatta Darboe; Adam Penn-Nicholson; Elisa Nemes; Mark Hatherill; Gregory Hussey; Hassan Mahomed; Michele Tameris; J Bruce McClain; Thomas G Evans; Willem A Hanekom; Thomas J Scriba; Helen McShane
Journal:  Nat Commun       Date:  2016-04-12       Impact factor: 14.919

10.  IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure.

Authors:  Chetan Seshadri; Galit Alter; Lenette L Lu; Malisa T Smith; Krystle K Q Yu; Corinne Luedemann; Todd J Suscovich; Patricia S Grace; Adam Cain; Wen Han Yu; Tanya R McKitrick; Douglas Lauffenburger; Richard D Cummings; Harriet Mayanja-Kizza; Thomas R Hawn; W Henry Boom; Catherine M Stein; Sarah M Fortune
Journal:  Nat Med       Date:  2019-05-20       Impact factor: 53.440

View more
  11 in total

Review 1.  BCG vaccination strategies against tuberculosis: updates and perspectives.

Authors:  Mengjin Qu; Xiangmei Zhou; Hao Li
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

2.  Identification of the Bartonella autotransporter CFA as a protective antigen and hypervariable target of neutralizing antibodies in mice.

Authors:  Lena K Siewert; Aleksandr Korotaev; Jaroslaw Sedzicki; Katja Fromm; Daniel D Pinschewer; Christoph Dehio
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-17       Impact factor: 12.779

3.  Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis.

Authors:  Nadege Nziza; Deniz Cizmeci; Leela Davies; Edward B Irvine; Wonyeong Jung; Brooke A Fenderson; Marwou de Kock; Willem A Hanekom; Kees L M C Franken; Cheryl L Day; Tom H M Ottenhoff; Galit Alter
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

4.  Antibodies: what makes us stronger.

Authors:  Natalia T Freund
Journal:  Hum Vaccin Immunother       Date:  2021-05-25       Impact factor: 4.526

Review 5.  Impact of antibiotics on the human microbiome and consequences for host health.

Authors:  Dhrati V Patangia; Cornelius Anthony Ryan; Eugene Dempsey; Reynolds Paul Ross; Catherine Stanton
Journal:  Microbiologyopen       Date:  2022-02       Impact factor: 3.139

6.  Monoclonal antibodies from humans with Mycobacterium tuberculosis exposure or latent infection recognize distinct arabinomannan epitopes.

Authors:  Elise Ishida; Devin T Corrigan; Ryan J Malonis; Daniel Hofmann; Tingting Chen; Anita G Amin; Delphi Chatterjee; Maju Joe; Todd L Lowary; Jonathan R Lai; Jacqueline M Achkar
Journal:  Commun Biol       Date:  2021-10-12

7.  Robust IgM responses following intravenous vaccination with Bacille Calmette-Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques.

Authors:  Sarah Fortune; Galit Alter; Edward B Irvine; Anthony O'Neil; Patricia A Darrah; Sally Shin; Alok Choudhary; Wenjun Li; William Honnen; Smriti Mehra; Deepak Kaushal; Hannah Priyadarshini Gideon; JoAnne L Flynn; Mario Roederer; Robert A Seder; Abraham Pinter
Journal:  Nat Immunol       Date:  2021-11-22       Impact factor: 31.250

Review 8.  Therapeutic Vaccines for Tuberculosis: An Overview.

Authors:  Rania Bouzeyen; Babak Javid
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

Review 9.  Immune evasion and provocation by Mycobacterium tuberculosis.

Authors:  Pallavi Chandra; Steven J Grigsby; Jennifer A Philips
Journal:  Nat Rev Microbiol       Date:  2022-07-25       Impact factor: 78.297

10.  Towards Reverse Vaccinology for Bovine TB: High Throughput Expression of Full Length Recombinant Mycobacterium bovis Proteins.

Authors:  Deepa Paliwal; Michelle Thom; Areej Hussein; Divyashree Ravishankar; Alex Wilkes; Bryan Charleston; Ian M Jones
Journal:  Front Mol Biosci       Date:  2022-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.